Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Pds Biotechnology Corp (PDSB)

40 + Investors. Track Smart Money conviction in PDSB. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -2
Streak
3Q ▼
Buyers last Q
49%

Smart Money Signals — PDSB

Based on 40 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds reduced or closed their PDSB positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🔻

Below peak — only 53% of 3.0Y high

53% of all-time peak
Only 40 funds hold PDSB today versus a peak of 76 funds at 2023 Q2 — just 53% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 17% fewer funds vs a year ago

fund count last 6Q
8 fewer hedge funds hold PDSB compared to a year ago (-17% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 49% buying

19 buying20 selling
Last quarter: 20 funds reduced or exited vs 19 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~9 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 13 → 9 → 9 → 9. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

48% of holders stayed for 2+ years

■ 48% conviction (2yr+) ■ 30% medium ■ 22% new
19 out of 40 hedge funds have held PDSB for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📊

Peak discovery — momentum slowing

9 → 13 → 9 → 9 → 9 new funds/Q
New funds entering each quarter: 13 → 9 → 9 → 9. PDSB is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Deep conviction — 52% of holders stayed 2+ years

■ 52% veterans ■ 20% 1-2yr ■ 28% new
Of 40 current holders: 21 (52%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 22% AUM from major funds

22% from top-100 AUM funds
12 of 40 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
1.3
out of 10
Low Exit Risk
Exit risk score 1.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — PDSB

In 2026 Q1, 19 hedge funds were net buyers of PDSB (9 opened a new position, 10 added to an existing one), while 20 reduced or exited (9 trimmed, 11 sold completely) — a 49% buyer ratio, indicating roughly balanced activity. This extends a 3-quarter selling streak, suggesting sustained institutional caution. 22% of total institutional value in PDSB is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -2 funds (more exits than new entries). Total institutional holders: 40.

Hedge Fund Ownership: PDSB

How many hedge funds hold PDSB — quarterly history vs. share price
Quarterly hedge fund ownership of PDSB vs. share price

Market Analysis: PDSB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: PDSB

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Pds Biotechnology Corp (PDSB) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much PDSB has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
PDSB
nan%
XLV
+2.1%

PDSB outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
PDSB
nan%
XLV
+3.2%

Since the filing became public, PDSB outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

5 top-rated funds 0 high-conviction
Consensus
3.4
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: PDSB
40 + Investors

Track Smart Money conviction in PDSB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 40 42 -4.76%
13F Shares 5M 8M -31.74%
Total Value $3M $6M -45.96%
New Positions 9 9 -
Increased Positions 10 11 -1
Closed Positions 11 15 -4
Reduced Positions 9 12 -3
Total Calls 2 0 100%
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: PDSB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

40 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in PDSB. Verified SEC 13F-HR filings.

QUARTER:
Top 25 PDSB holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Act Capital Management, LLC 0.01% 30,000 $18K
2 Inspirion Wealth Advisors, LLC 0.01% 181,995 $110K
3 Tempus Wealth Planning, LLC 0.01% 61,800 $37K
4 NINE MASTS CAPITAL Ltd 0.01% 67,507 $41K
5 Iron Gate Global Advisors LLC 0.00% 75,022 $45K
6 Two Sigma Securities, LLC 0.00% 31,481 $19K
7 Armistice Capital, LLC 0.00% 173,605 $105K
8 Caption Management, LLC 0.00% 319,100 $193K
9 Blair William & Co/Il 0.00% 300,000 $182K
10 XTX Topco Ltd 0.00% 36,211 $22K
11 Grandfield & Dodd, LLC 0.00% 10,000 $6K
12 Renaissance Technologies LLC 0.00% 220,800 $134K
13 Creative Financial Designs Inc /Adv 0.00% 3,000 $2K
14 Commonwealth Equity Services, LLC 0.00% 90,797 $55K
15 Truvestments Capital LLC 0.00% 655 —
16 Vanguard Fiduciary Trust Co 0.00% 307,311 $186K
17 United Capital Financial Advisors, LLC 0.00% 12,000 $7K
18 DAVENPORT & Co LLC 0.00% 10,000 $6K
19 Federation des caisses Desjardins du Quebec 0.00% 14,800 $9K
20 Rockefeller Capital Management L.P. 0.00% 27,664 $17K
21 Vanguard Capital Management LLC 0.00% 1,631,089 $987K
22 Wells Fargo & Company/Mn 0.00% 110,500 $67K
23 BlackRock, Inc. 0.00% 554,048 $335K
24 UBS Group AG 0.00% 56,004 $34K
25 Group One Trading LLC 0.00% 3,567 $2K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Pds Biotechnology Corp (PDSB)

What does the Smart Money Trend signal show for PDSB?

Selling streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds reduced or closed their PDSB positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for PDSB?

More sellers than buyers — 49% buying: Last quarter: 20 funds reduced or exited vs 19 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for PDSB holders?

Strong quality — 22% AUM from major funds: 12 of 40 holders rank in the top 100 by AUM, accounting for 22% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held PDSB?

48% of holders stayed for 2+ years: 19 out of 40 hedge funds have held PDSB for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Pds Biotechnology Corp (PDSB) following the 2026 Q1 hedge fund 13F filings?

As of today, PDSB has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), PDSB has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →